Immune tolerance induction by integrating innate and adaptive immune regulators

Cell Transplantation

Volumn 19, Issue 3, 2010, Pages 253-268

  Suzuki, Jun ^a   Ricordi, Camillo ^a,b,c   Chen, Zhibin ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autoimmunity; CTLA4; Immune tolerance; Immunosuppression; Regulatory cells; Transplant

Indexed keywords

B7 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ANTIBODY; RAPAMYCIN; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ALLOTRANSPLANTATION; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; GENE EXPRESSION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; CELL COMMUNICATION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; T-LYMPHOCYTES, REGULATORY; TISSUE THERAPY;

ERAGROSTIS TEF;

EID: 77953732636     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X480314     Document Type: Review

References (145)

1. Adams, A. B.; Shirasugi, N.; Durham, M. M.; Strobert, E.; Anderson, D.; Rees, P.; Cowan, S.; Xu, H.; Blinder, Y.; Cheung, M.; Hollenbaugh, D.; Kenyon, N. S.; Pearson, T. C.; Larsen, C. P. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in non-human primates. Diabetes 51(2):265-270; 2002.
2. Anjos, S. M.; Tessier, M. C.; Polychronakos, C. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block. J. Clin. Endocrinol. Metab. 89(12):6257-6265; 2004.
3. Annacker, O.; Pimenta-Araujo, R.; Burlen-Defranoux, O.; Barbosa, T. C.; Cumano, A.; Bandeira, A. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166(5):3008-3018; 2001.
4. Azarian, M.; Busson, M.; Lepage, V.; Charron, D.; Toubert, A.; Loiseau, P.; de Latour, R. P.; Rocha, V.; Socie, G. Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical haematopoietic stem-cell transplantations. Blood 110(13): 4623-4624; 2007.
5. Baniasadi, V.; Narain, N.; Goswami, R.; Das, S. N. Promoter region -318 C/T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 67(5):383-389; 2006.
6. Barthlott, T.; Kassiotis, G.; Stockinger, B. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197(4):451-460; 2003.
7. Battaglia, M.; Stabilini, A.; Roncarolo, M. G. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 105(12):4743-4748; 2005.
8. Bellin, M. D.; Kandaswamy, R.; Parkey, J.; Zhang, H. J.; Liu, B.; Ihm, S. H.; Ansite, J. D.; Witson, J.; Bansal- Pakala, P.; Balamurugan, A. N.; Papas, K.; Sutherland, D. E.; Moran, A.; Hering, B. J. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am. J. Transplant. 8(11):2463-2470; 2008.
9. Berney, T.; Ferrari-Lacraz, S.; Buhler, L.; Oberholzer, J.; Marangon, N.; Philippe, J.; Villard, J.; Morel, P. Longterm insulin-independence after allogeneic islet transplantation for type 1 diabetes: Over the 10-year mark. Am. J. Transplant. 9(2):419-423; 2009.
10. Billingham, R. E.; Brent, L.; Medawar, P. B. Actively acquired tolerance of foreign cells. Nature 172(4379): 603-606; 1953.
11. Bjornvold, M.; Amundsen, S. S.; Stene, L. C.; Joner, G.; Dahl-Jorgensen, K.; Njolstad, P. R.; Ek, J.; Ascher, H.; Gudjonsdottir, A. H.; Lie, B. A.; Skinningsrud, B.; Akselsen, H. E.; Ronningen, K. S.; Sollid, L. M.; Undlien, D. E. FOXP3 polymorphisms in type 1 diabetes and coeliac disease. J. Autoimmun. 27(2):140-144; 2006.
12. Bluestone, J. A.; St Clair, E. W.; Turka, L. A. CTLA4Ig: Bridging the basic immunology with clinical application. Immunity 24(3):233-238; 2006.
13. Bretscher, P. A.; Cohn, M. Minimal model for the mechanism of antibody induction and paralysis by antigen. Nature 220(5166):444-448; 1968.
14. Broady, R.; Yu, J.; Levings, M. K. ATG-induced expression of FOXP3 in human CD4+ T cells in vitro is associated with T cell activation and not the induction of FOXP3+ T regulatory cells. Blood 114:5003-5009; 2009.
15. Brode, S.; Raine, T.; Zaccone, P.; Cooke, A. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177(10):6603-6612; 2006.
16. Brusko, T.; Wasserfall, C.; McGrail, K.; Schatz, R.; Viener, H. L.; Schatz, D.; Haller, M.; Rockell, J.; Gottlieb, P.; Clare-Salzler, M.; Atkinson, M. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 56(3):604-612; 2007.
17. Chambers, C. A.; Cado, D.; Truong, T.; Allison, J. P. Thymocyte development is normal in CTLA-4-deficient mice. Proc. Natl. Acad. Sci. USA 94(17):9296-9301; 1997.
18. Chatenoud, L.; Bluestone, J. A. CD3-specific antibodies: A portal to the treatment of autoimmunity. Nat. Rev. Immunol. 7(8):622-632; 2007.
19. Chen, L.; Wang, T.; Zhou, P.; Ma, L.; Yin, D.; Shen, J.; Molinero, L.; Nozaki, T.; Phillips, T.; Uematsu, S.; Akira, S.; Wang, C. R.; Fairchild, R. L.; Alegre, M. L.; Chong, A. TLR engagement prevents transplantation tolerance. Am. J. Transplant. 6(10):2282-2291; 2006.
20. Chen, Z.; Benoist, C.; Mathis, D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc. Natl. Acad. Sci. USA 102(41):14735-14740; 2005.
21. Chen, Z.; Herman, A. E.; Matos, M.; Mathis, D.; Benoist, C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202(10):1387-1397; 2005.
22. Chen, Z.; Stockton, J.; Mathis, D.; Benoist, C. Modeling CTLA4-linked autoimmunity with RNA interference in mice. Proc. Natl. Acad. Sci. USA 103(44):16400-16405; 2006.
23. Chiang, Y. J.; Lu, L.; Fung, J. J.; Qian, S. Liver-derived dendritic cells induce donor-specific hyporesponsiveness: Use of sponge implant as a cell transplant model. Cell Transplant. 10(3):343-350; 2001.
24. Chikuma, S.; Abbas, A. K.; Bluestone, J. A. B7-independent inhibition of T cells by CTLA-4. J. Immunol. 175(1):177-181; 2005.
25. Choi, J. M.; Ahn, M. H.; Chae, W. J.; Jung, Y. G.; Park, J. C.; Song, H. M.; Kim, Y. E.; Shin, J. A.; Park, C. S.; Park, J. W.; Park, T. K.; Lee, J. H.; Seo, B. F.; Kim, K. D.; Kim, E. S.; Lee, D. H.; Lee, S. K.; Lee, S. K. Intranasal delivery of the cytoplasmic domain of CTLA- 4 using a novel protein transduction domain prevents allergic inflammation. Nat. Med. 12(5):574-579; 2006.
26. D'Alise, A. M.; Auyeung, V.; Feuerer, M.; Nishio, J.; Fontenot, J.; Benoist, C.; Mathis, D. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. USA 105(50):19857-19862; 2008.
27. Derks, R. A.; Burlingham, W. J. In vitro parameters of donor-antigen-specific tolerance. Curr. Opin. Immunol. 17(5):560-564; 2005.
28. Dugast, A. S.; Haudebourg, T.; Coulon, F.; Heslan, M.; Haspot, F.; Poirier, N.; Vuillefroy de Silly, R.; Usal, C.; Smit, H.; Martinet, B.; Thebault, P.; Renaudin, K.; Vanhove, B. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J. Immunol. 180(12):7898-7906; 2008.
29. Eggena, M. P.; Walker, L. S.; Nagabhushanam, V.; Barron, L.; Chodos, A.; Abbas, A. K. Cooperative roles of CTLA-4 and regulatory T cells in tolerance to an islet cell antigen. J. Exp. Med. 199(12):1725-1730; 2004.
30. Fallarino, F.; Grohmann, U.; Hwang, K. W.; Orabona, C.; Vacca, C.; Bianchi, R.; Belladonna, M. L.; Fioretti, M. C.; Alegre, M. L.; Puccetti, P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4(12):1206-1212; 2003.
31. Faradji, R. N.; Tharavanij, T.; Messinger, S.; Froud, T.; Pileggi, A.; Monroy, K.; Mineo, D.; Baidal, D. A.; Cure, P.; Ponte, G.; Mendez, A. J.; Selvaggi, G.; Ricordi, C.; Alejandro, R. Longterm insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation 86(12):1658-1665; 2008.
32. Fecteau, S.; Basadonna, G. P.; Freitas, A.; Ariyan, C.; Sayegh, M. H.; Rothstein, D. M. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat. Immunol. 2(1):58-63; 2001.
33. Feng, X.; Kajigaya, S.; Solomou, E. E.; Keyvanfar, K.; Xu, X.; Raghavachari, N.; Munson, P. J.; Herndon, T. M.; Chen, J.; Young, N. S. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOX P3+ regulatory T cells in vitro. Blood 111(7):3675-3683; 2008.
34. Fort, A.; Fort, N.; Ricordi, C.; Stabler, C. L. Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas. Cell Transplant. 17(9):997-1003; 2008.
35. Friedline, R. H.; Brown, D. S.; Nguyen, H.; Kornfeld, H.; Lee, J.; Zhang, Y.; Appleby, M.; Der, S. D.; Kang, J.; Chambers, C. A. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J. Exp. Med. 206(2):421-434; 2009.
36. Fu, F.; Li, Y.; Qian, S.; Lu, L.; Chambers, F.; Starzl, T. E.; Fung, J. J.; Thomson, A. W. Costimulatory molecule- deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62(5): 659-665; 1996.
37. Fu, Y. X.; Watson, G.; Jimenez, J. J.; Wang, Y.; Lopez, D. M. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res. 50(2): 227-234; 1990.
38. Gabrilovich, D. I.; Bronte, V.; Chen, S. H.; Colombo, M. P.; Ochoa, A.; Ostrand-Rosenberg, S.; Schreiber, H. The terminology issue for myeloid-derived suppressor cells. Cancer Res. 67(1):425; author reply 426; 2007.
39. Gabrilovich, D. I.; Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9(3):162-174; 2009.
40. Garrovillo, M.; Ali, A.; Oluwole, S. F. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. Transplantation 68(12): 1827-1834; 1999.
41. Germain, R. N.; Bajenoff, M.; Castellino, F.; Chieppa, M.; Egen, J. G.; Huang, A. Y.; Ishii, M.; Koo, L. Y.; Qi, H. Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging. Immunol. Rev. 221:163-181; 2008.
42. Gilboa, E. DC-based cancer vaccines. J. Clin. Invest. 117(5):1195-1203; 2007.
43. Gilboa, E. The promise of cancer vaccines. Nat. Rev. Cancer 4(5):401-411; 2004.
44. Golshayan, D.; Jiang, S.; Tsang, J.; Garin, M. I.; Mottet, C.; Lechler, R. I. In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 109(2):827-835; 2007.
45. Gonzalez, A.; Katz, J. D.; Mattei, M. G.; Kikutani, H.; Benoist, C.; Mathis, D. Genetic control of diabetes progression. Immunity 7(6):873-883; 1997.
46. Gorgi, Y.; Sfar, I.; Abdallah, T. B.; Abderrahim, E.; Ayed, S. J.; Aouadi, H.; Bardi, R.; Ayed, K. Ctla-4 exon 1 (+49) and promoter (-318) gene polymorphisms in kidney transplantation. Transplant. Proc. 38(7):2303-2305; 2006.
47. Graca, L.; Cobbold, S. P.; Waldmann, H. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195(12):1641-1646; 2002.
48. Groux, H.; O'Garra, A.; Bigler, M.; Rouleau, M.; Antonenko, S.; de Vries, J. E.; Roncarolo, M. G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737-742; 1997.
49. Gruber, S. A. Locoregional immunosuppression of organ transplants. Immunol. Rev. 129:5-30; 1992.
50. Han, D.; Xu, X.; Baidal, D.; Leith, J.; Ricordi, C.; Alejandro, R.; Kenyon, N. S. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: Elevation precedes clinical evidence of rejection. Diabetes 53(9):2281-2290; 2004.
51. Haskins, K.; Portas, M.; Bergman, B.; Lafferty, K.; Bradley, B. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 86(20):8000-8004; 1989.
52. Haskins, K.; Portas, M.; Bradley, B.; Wegmann, D.; Lafferty, K. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37(10):1444-1448; 1988.
53. Hu, C. Y.; Rodriguez-Pinto, D.; Du, W.; Ahuja, A.; Henegariu, O.; Wong, F. S.; Shlomchik, M. J.; Wen, L. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117(12):3857-3867; 2007.
54. Hwang, K. W.; Sweatt, W. B.; Mashayekhi, M.; Palucki, D. A.; Sattar, H.; Chuang, E.; Alegre, M. L. Transgenic expression of CTLA-4 controls lymphoproliferation in IL-2-deficient mice. J. Immunol. 173(9):5415-5424; 2004.
55. Ilkovitch, D.; Lopez, D. M. The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res. 69(13):5514-5521; 2009.
56. Joffre, O.; Santolaria, T.; Calise, D.; Al Saati, T.; Hudrisier, D.; Romagnoli, P.; van Meerwijk, J. P. Prevention of acute and chronic allograft rejection with CD4+ CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14(1):88-92; 2008.
57. Johnson, J. D.; Ao, Z.; Ao, P.; Li, H.; Dai, L.; He, Z.; Tee, M.; Potter, K. J.; Klimek, A. M.; Meloche, R. M.; Thompson, D. M.; Verchere, C. B.; Warnock, G. L. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant. 18:833-845; 2009.
58. Katz, J. D.; Wang, B.; Haskins, K.; Benoist, C.; Mathis, D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74(6):1089-1100; 1993.
59. Kaufmann, D. E.; Kavanagh, D. G.; Pereyra, F.; Zaunders, J. J.; Mackey, E. W.; Miura, T.; Palmer, S.; Brockman, M.; Rathod, A.; Piechocka-Trocha, A.; Baker, B.; Zhu, B.; Le Gall, S.; Waring, M. T.; Ahern, R.; Moss, K.; Kelleher, A. D.; Coffin, J. M.; Freeman, G. J.; Rosenberg, E. S.; Walker, B. D. Upregulation of CTLA- 4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 8(11):1246-1254; 2007.
60. Kawai, T.; Cosimi, A. B.; Spitzer, T. R.; Tolkoff-Rubin, N.; Suthanthiran, M.; Saidman, S. L.; Shaffer, J.; Preffer, F. I.; Ding, R.; Sharma, V.; Fishman, J. A.; Dey, B.; Ko, D. S.; Hertl, M.; Goes, N. B.; Wong, W.; Williams, Jr., W. W.; Colvin, R. B.; Sykes, M.; Sachs, D. H. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358(4):353-361; 2008.
61. Kim, J.; Rasmussen, J.; Rudensky, A. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8(2):191-197; 2007.
62. Kryczek, I.; Zou, L.; Rodriguez, P.; Zhu, G.; Wei, S.; Mottram, P.; Brumlik, M.; Cheng, P.; Curiel, T.; Myers, L.; Lackner, A.; Alvarez, X.; Ochoa, A.; Chen, L.; Zou, W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med. 203(4):871-881; 2006.
63. Kuo, T. K.; Ho, J. H.; Lee, O. K. Mesenchymal stem cell therapy for nonmusculoskeletal diseases: Emerging applications. Cell Transplant. 18:1013-1028; 2009.
64. Lakey, J. R.; Warnock, G. L.; Shapiro, A. M.; Korbutt, G. S.; Ao, Z.; Kneteman, N. M.; Rajotte, R. V. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant. 8(3):285-292; 1999.
65. Lawson, J. M.; Tremble, J.; Dayan, C.; Beyan, H.; Leslie, R. D.; Peakman, M.; Tree, T. I. Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin. Exp. Immunol. 154(3):353-359; 2008.
66. Ligers, A.; Teleshova, N.; Masterman, T.; Huang, W. X.; Hillert, J. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2(3): 145-152; 2001.
67. Lin, H.; Rathmell, J. C.; Gray, G. S.; Thompson, C. B.; Leiden, J. M.; Alegre, M. L. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 188(1):199-204; 1998.
68. Linsley, P. S.; Clark, E. A.; Ledbetter, J. A. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA 87(13):5031-5035; 1990.
69. Liu, C.; Noorchashm, H.; Sutter, J. A.; Naji, M.; Prak, E. L.; Boyer, J.; Green, T.; Rickels, M. R.; Tomaszewski, J. E.; Koeberlein, B.; Wang, Z.; Paessler, M. E.; Velidedeoglu, E.; Rostami, S. Y.; Yu, M.; Barker, C. F.; Naji, A. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat. Med. 13(11):1295-1298; 2007.
70. Long, S. A.; Walker, M. R.; Rieck, M.; James, E.; Kwok, W. W.; Sanda, S.; Pihoker, C.; Greenbaum, C.; Nepom, G. T.; Buckner, J. H. Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects. Eur. J. Immunol. 39(2):612-620; 2009.
71. Lu, L.; Rudert, W. A.; Qian, S.; McCaslin, D.; Fu, F.; Rao, A. S.; Trucco, M.; Fung, J. J.; Starzl, T. E.; Thomson, A. W. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 182(2):379-387; 1995.
72. Lundholm, M.; Motta, V.; Lofgren-Burstrom, A.; Duarte, N.; Bergman, M. L.; Mayans, S.; Holmberg, D. Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1. Diabetes 55(2):538-544; 2006.
73. Masteller, E. L.; Chuang, E.; Mullen, A. C.; Reiner, S. L.; Thompson, C. B. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164(10):5319-5327; 2000.
74. Masteller, E. L.; Warner, M. R.; Tang, Q.; Tarbell, K. V.; McDevitt, H.; Bluestone, J. A. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol. 175(5):3053-3059; 2005.
75. Mathis, D.; Benoist, C. Back to central tolerance. Immunity 20(5):509-516; 2004.
76. Mellor, A. Indoleamine 2,3 dioxygenase and regulation of T cell immunity. Biochem. Biophys. Res. Commun. 338(1):20-24; 2005.
77. Metz, R.; Duhadaway, J. B.; Kamasani, U.; Laury-Klein- top, L.; Muller, A. J.; Prendergast, G. C. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 67(15):7082-7087; 2007.
78. Mineo, D.; Pileggi, A.; Alejandro, R.; Ricordi, C. Point: Steady progress and current challenges in clinical islet transplantation. Diabetes Care 32(8):1563-1569; 2009.
79. Monti, P.; Scirpoli, M.; Maffi, P.; Ghidoli, N.; De Taddeo, F.; Bertuzzi, F.; Piemonti, L.; Falcone, M.; Secchi, A.; Bonifacio, E. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J. Clin. Invest. 118(5):1806-1814; 2008.
80. Morelli, A. E.; Thomson, A. W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7(8):610-621; 2007.
81. Movahedi, K.; Guilliams, M.; Van den Bossche, J.; Van den Bergh, R.; Gysemans, C.; Beschin, A.; De Baetselier, P.; Van Ginderachter, J. A. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111(8):4233-4244; 2008.
82. Muthukumar, T.; Dadhania, D.; Ding, R.; Snopkowski, C.; Naqvi, R.; Lee, J. B.; Hartono, C.; Li, B.; Sharma, V. K.; Seshan, S. V.; Kapur, S.; Hancock, W. W.; Schwartz, J. E.; Suthanthiran, M. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N. Engl. J. Med. 353(22):2342-2351; 2005.
83. Nanji, S. A.; Hancock, W. W.; Luo, B.; Schur, C. D.; Pawlick, R. L.; Zhu, L. F.; Anderson, C. C.; Shapiro, A. M. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes 55(1):27-33; 2006.
84. Newell, K. A.; Larsen, C. P. Tolerance assays: Measuring the unknown. Transplantation 81(11):1503-1509; 2006.
85. Nir, T.; Melton, D. A.; Dor, Y. Recovery from diabetes in mice by beta cell regeneration. J. Clin. Invest. 117(9): 2553-2561; 2007.
86. Nolan, K.; Millet, Y.; Ricordi, C.; Stabler, C. L. Tissue engineering and biomaterials in regenerative medicine. Cell Transplant. 17(3):241-243; 2008.
87. Ostrand-Rosenberg, S.; Sinha, P. Myeloid-derived suppressor cells: Linking inflammation and cancer. J. Immunol. 182(8):4499-4506; 2009.
88. Ou, D.; Wang, X.; Metzger, D. L.; Ao, Z.; Pozzilli, P.; James, R. F.; Chen, L.; Warnock, G. L. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant. 15(5):399-410; 2006.
89. Peggs, K. S.; Quezada, S. A.; Chambers, C. A.; Korman, A. J.; Allison, J. P. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J. Exp. Med. 206(8):1717-1725; 2009.
90. Perez-Garcia, A.; De la Camara, R.; Roman-Gomez, J.; Jimenez-Velasco, A.; Encuentra, M.; Nieto, J. B.; de la Rubia, J.; Urbano-Ispizua, A.; Brunet, S.; Iriondo, A.; Gonzalez, M.; Serrano, D.; Espigado, I.; Solano, C.; Ribera, J. M.; Pujal, J. M.; Hoyos, M.; Gallardo, D. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood 110(1):461-467; 2007.
91. Pileggi, A.; Molano, R. D.; Ricordi, C.; Zahr, E.; Collins, J.; Valdes, R.; Inverardi, L. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation 81(9):1318-1324; 2006.
92. Powrie, F.; Carlino, J.; Leach, M. W.; Mauze, S.; Coffman, R. L. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J. Exp. Med. 183(6):2669-2674; 1996.
93. Putnam, A. L.; Brusko, T. M.; Lee, M. R.; Liu, W.; Szot, G. L.; Ghosh, T.; Atkinson, M. A.; Bluestone, J. A. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58(3):652-662; 2009.
94. Read, S.; Malmstrom, V.; Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192(2): 295-302; 2000.
95. Ricordi, C.; Lacy, P. E.; Finke, E. H.; Olack, B. J.; Scharp, D. W. Automated method for isolation of human pancreatic islets. Diabetes 37(4):413-420; 1988.
96. Ricordi, C.; Strom, T. B. Clinical islet transplantation: Advances and immunological challenges. Nat. Rev. Immunol. 4(4):259-268; 2004.
97. Riley, J. L.; June, C. H.; Blazar, B. R. Human T regulatory cell therapy: Take a billion or so and call me in the morning. Immunity 30(5):656-665; 2009.
98. Roncarolo, M. G.; Battaglia, M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 7(8):585-598; 2007.
99. Ruzek, M. C.; Waire, J. S.; Hopkins, D.; Lacorcia, G.; Sullivan, J.; Roberts, B. L.; Richards, S. M.; Nahill, S. R.; Williams, J. M.; Scaria, A.; Dzuris, J.; Shankara, S.; Garman, R. D. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood 111(3): 1726-1734; 2008.
100. Sakaguchi, S.; Sakaguchi, N.; Asano, M.; Itoh, M.; Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155(3): 1151-1164; 1995.
101. Sakaguchi, S.; Yamaguchi, T.; Nomura, T.; Ono, M. Regulatory T cells and immune tolerance. Cell 133(5): 775-787; 2008.
102. Salomon, B.; Lenschow, D. J.; Rhee, L.; Ashourian, N.; Singh, B.; Sharpe, A.; Bluestone, J. A. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12(4):431-440; 2000.
103. Schneider, A.; Rieck, M.; Sanda, S.; Pihoker, C.; Greenbaum, C.; Buckner, J. H. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J. Immunol. 181(10):7350-7355; 2008.
104. Schneider, H.; Downey, J.; Smith, A.; Zinselmeyer, B. H.; Rush, C.; Brewer, J. M.; Wei, B.; Hogg, N.; Garside, P.; Rudd, C. E. Reversal of the TCR stop signal by CTLA-4. Science 313(5795):1972-1975; 2006.
105. Segundo, D. S.; Ruiz, J. C.; Izquierdo, M.; Fernandez-Fresnedo, G.; Gomez-Alamillo, C.; Merino, R.; Benito, M. J.; Cacho, E.; Rodrigo, E.; Palomar, R.; Lopez-Hoyos, M.; Arias, M. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 82(4):550-557; 2006.
106. Selmani, Z.; Naji, A.; Zidi, I.; Favier, B.; Gaiffe, E.; Obert, L.; Borg, C.; Saas, P.; Tiberghien, P.; Rouas-Freiss, N.; Carosella, E. D.; Deschaseaux, F. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26(1):212-222; 2008.
107. Sgouroudis, E.; Piccirillo, C. A. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease. Diabetes Metab. Res. Rev. 25(3):208-218; 2009.
108. Shapiro, A. M.; Ricordi, C.; Hering, B. J.; Auchincloss, H.; Lindblad, R.; Robertson, R. P.; Secchi, A.; Brendel, M. D.; Berney, T.; Brennan, D. C.; Cagliero, E.; Alejandro, R.; Ryan, E. A.; DiMercurio, B.; Morel, P.; Polonsky, K. S.; Reems, J. A.; Bretzel, R. G.; Bertuzzi, F.; Froud, T.; Kandaswamy, R.; Sutherland, D. E.; Eisen-barth, G.; Segal, M.; Preiksaitis, J.; Korbutt, G. S.; Barton, F. B.; Viviano, L.; Seyfert-Margolis, V.; Bluestone, J.; Lakey, J. R. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355(13): 1318-1330; 2006.
109. Shevach, E. M. Immunology. Regulating suppression. Science 322(5899):202-203; 2008.
110. Sinha, P.; Okoro, C.; Foell, D.; Freeze, H. H.; Ostrand-Rosenberg, S.; Srikrishna, G. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 181(7):4666-4675; 2008.
111. Stamper, C. C.; Zhang, Y.; Tobin, J. F.; Erbe, D. V.; Ikemizu, S.; Davis, S. J.; Stahl, M. L.; Seehra, J.; Somers, W. S.; Mosyak, L. Crystal structure of the B7-1/ CTLA-4 complex that inhibits human immune responses. Nature 410(6828):608-611; 2001.
112. Steinman, R. M.; Banchereau, J. Taking dendritic cells into medicine. Nature 449(7161):419-426; 2007.
113. Steinman, R. M.; Cohn, Z. A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137(5):1142-1162; 1973.
114. Takahashi, T.; Tagami, T.; Yamazaki, S.; Uede, T.; Shimizu, J.; Sakaguchi, N.; Mak, T. W.; Sakaguchi, S. Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192(2):303-310; 2000.
115. Tang, Q.; Henriksen, K. J.; Bi, M.; Finger, E. B.; Szot, G.; Ye, J.; Masteller, E. L.; McDevitt, H.; Bonyhadi, M.; Bluestone, J. A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199(11):1455-1465; 2004.
116. Tarbell, K. V.; Petit, L.; Zuo, X.; Toy, P.; Luo, X.; Mqadmi, A.; Yang, H.; Suthanthiran, M.; Mojsov, S.; Steinman, R. M. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 204(1): 191-201; 2007.
117. Tarbell, K. V.; Yamazaki, S.; Olson, K.; Toy, P.; Steinman, R. M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199(11): 1467-1477; 2004.
118. Taylor, P. A.; Noelle, R. J.; Blazar, B. R. CD4(+) CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193(11):1311-1318; 2001.
119. Teft, W. A.; Kirchhof, M. G.; Madrenas, J. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 24:65-97; 2006.
120. Thompson, C. B.; Allison, J. P. The emerging role of CTLA-4 as an immune attenuator. Immunity 7(4):445-450; 1997.
121. Thomson, A. W.; Fairchild, R. L. The last 5 years of basic science investigation in transplant immunology. Am. J. Transplant. 6(8):1768-1773; 2006.
122. Torrealba, J. R.; Katayama, M.; Fechner, Jr., J. H.; Jankowska- Gan, E.; Kusaka, S.; Xu, Q.; Schultz, J. M.; Oberley, T. D.; Hu, H.; Hamawy, M. M.; Jonker, M.; Wubben, J.; Doxiadis, G.; Bontrop, R.; Burlingham, W. J.; Knechtle, S. J. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J. Immunol. 172(9): 5753-5764; 2004.
123. Trenado, A.; Charlotte, F.; Fisson, S.; Yagello, M.; Klatzmann, D.; Salomon, B. L.; Cohen, J. L. Recipient- type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. 112(11):1688-1696; 2003.
124. Truong, W.; Hancock, W. W.; Anderson, C. C.; Merani, S.; Shapiro, A. M. Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant. 15(2): 105-119; 2006.
125. Tsang, J. Y.; Tanriver, Y.; Jiang, S.; Xue, S. A.; Ratnasothy, K.; Chen, D.; Stauss, H. J.; Bucy, R. P.; Lombardi, G.; Lechler, R. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J. Clin. Invest. 118(11): 3619-3628; 2008.
126. Turka, L. A.; Lechler, R. I. Towards the identification of biomarkers of transplantation tolerance. Nat. Rev. Immunol. 9(7):521-526; 2009.
127. Ueda, H.; Howson, J. M.; Esposito, L.; Heward, J.; Snook, H.; Chamberlain, G.; Rainbow, D. B.; Hunter, K. M.; Smith, A. N.; Di Genova, G.; Herr, M. H.; Dahlman, I.; Payne, F.; Smyth, D.; Lowe, C.; Twells, R. C.; Howlett, S.; Healy, B.; Nutland, S.; Rance, H. E.; Everett, V.; Smink, L. J.; Lam, A. C.; Cordell, H. J.; Walker, N. M.; Bordin, C.; Hulme, J.; Motzo, C.; Cucca, F.; Hess, J. F.; Metzker, M. L.; Rogers, J.; Gregory, S.; Allahabadia, A.; Nithiyananthan, R.; Tuomilehto-Wolf, E.; Tuomilehto, J.; Bingley, P.; Gillespie, K. M.; Undlien, D. E.; Ronningen, K. S.; Guja, C.; Ionescu-Tirgoviste, C.; Savage, D. A.; Maxwell, A. P.; Carson, D. J.; Patterson, C. C.; Franklyn, J. A.; Clayton, D. G.; Peterson, L. B.; Wicker, L. S.; Todd, J. A.; Gough, S. C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506-511; 2003.
128. van der Windt, D. J.; Echeverri, G. J.; Ijzermans, J. N.; Cooper, D. K. The choice of anatomical site for islet transplantation. Cell Transplant. 17(9):1005-1014; 2008.
129. Vincenti, F.; Larsen, C.; Durrbach, A.; Wekerle, T.; Nashan, B.; Blancho, G.; Lang, P.; Grinyo, J.; Halloran, P. F.; Solez, K.; Hagerty, D.; Levy, E.; Zhou, W.; Natarajan, K.; Charpentier, B. Costimulation blockade with belatacept in renal transplantation. N. Engl. J. Med. 353(8):770-781; 2005.
130. Waldmann, H.; Adams, E.; Fairchild, P.; Cobbold, S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212:301-313; 2006.
131. Waldmann, H.; Cobbold, S. Exploiting tolerance processes in transplantation. Science 305(5681):209-212; 2004.
132. Wang, X. B.; Zhao, X.; Giscombe, R.; Lefvert, A. K. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun. 3(4):233-234; 2002.
133. Waterhouse, P.; Bachmann, M. F.; Penninger, J. M.; Ohashi, P. S.; Mak, T. W. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 27(8):1887-1892; 1997.
134. Wee, Y. M.; Lim, D. G.; Kim, Y. H.; Kim, J. H.; Kim, S. C.; Yu, E.; Park, M. O.; Choi, M. Y.; Park, Y. H.; Jang, H. J.; Cho, E. Y.; Cho, M. H.; Han, D. J. Cell surface modification by activated polyethylene glycol prevents allosensitization after islet transplantation. Cell Transplant. 17(10-11):1257-1269; 2008.
135. Wildin, R. S.; Smyk-Pearson, S.; Filipovich, A. H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 39(8):537-545; 2002.
136. Wing, K.; Onishi, Y.; Prieto-Martin, P.; Yamaguchi, T.; Miyara, M.; Fehervari, Z.; Nomura, T.; Sakaguchi, S. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322(5899):271-275; 2008.
137. Wisniewski, A.; Kusztal, M.; Magott-Procelewska, M.; Klinger, M.; Jasek, M.; Luszczek, W.; Nowak, I.; Kosmaczewska, A.; Ciszak, L.; Frydecka, I.; Gorski, A.; Kusnierczyk, P. Possible association of cytotoxic Tlymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant. Transplant. Proc. 38(1):56-58; 2006.
138. Wood, K. J.; Sakaguchi, S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3(3):199-210; 2003.
139. Wu, Z.; Bensinger, S. J.; Zhang, J.; Chen, C.; Yuan, X.; Huang, X.; Markmann, J. F.; Kassaee, A.; Rosengard, B. R.; Hancock, W. W.; Sayegh, M. H.; Turka, L. A. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10(1):87-92; 2004.
140. Xia, M.; Gasser, J.; Feige, U. Dexamethasone enhances CTLA-4 expression during T cell activation. Cell. Mol. Life Sci. 55(12):1649-1656; 1999.
141. Yang, R.; Cai, Z.; Zhang, Y.; Yutzy, W. H. t.; Roby, K. F.; Roden, R. B. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res. 66(13):6807-6815; 2006.
142. Yi, K. H.; Chen, L. Fine tuning the immune response through B7-H3 and B7-H4. Immunol. Rev. 229(1):145-151; 2009.
143. Zhang, H.; Ohmi, K.; Hirasawa, A.; Enosawa, S.; Hara, Y.; Tamura, A.; Tsujimoto, G. Immunological toler ance-related genes in a spontaneous tolerant model of rat liver transplantation explored by suppression subtractive hybridization. Cell Transplant. 17(1-2):195-201; 2008. (Pubitemid 351551396)
144. Zhang, W.; Liang, S.; Wu, J.; Horuzsko, A. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86(8):1125-1134; 2008.
145. Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6(4):295-307; 2006.